Use of hormone replacement therapyBMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7058.686 (Published 14 September 1996) Cite this as: BMJ 1996;313:686
Evidence on risk of breast cancer associated with hormone replacement therapy is still inconclusive
- Karen Mckinney, Senior registrar
- Department of Obstetrics and Gynaecology, Queen's University of Belfast, Institute of Clinical Science, Belfast, BT7 1NN
EDITOR,—As a female doctor who has a specialist interest in the menopause and hormone replacement therapy, I was interested to read Elizabeth H Price and Helen Kaye Little's letter about hormone replacement therapy.1 I agree that women need to be informed about the risks associated with such treatment. I disagree, however, with the authors' statements about the increased risk of breast cancer.
The epidemiological evidence on the effect of combined treatment with …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial